Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
AbCellera Biologics Inc. (ABCL)


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-06-09 Thermopylae Holdings Ltd. 10%-Owner Sell 5,598,420 $24.03 $134,530,033 No
2021-06-09 Hansen Carl L. G. Chief Executive Officer Sell 6,000,000 $24.13 $144,770,323 No
2021-06-09 Lecault Veronique Chief Operating Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Stimart Tryn Chief Legal Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Falconer Ester Chief Technology Officer Sell 1,000,000 $25.50 $25,500,000 No
2021-06-09 Booth Andrew Chief Financial Officer Sell 1,200,000 $25.50 $30,600,000 No
2020-12-15 THIEL PETER Director Buy 3,000,000 $20.00 $60,000,000 Yes
2020-12-15 Montalbano John S. Director Buy 25,000 $20.00 $500,000 Yes
2020-12-15 Lecault Veronique Chief Operating Officer Buy 23,000 $20.00 $460,000 Yes
2020-12-15 Hayden Michael R Director Buy 73,665 $20.00 $1,473,300 Yes
2020-12-15 Stimart Tryn Chief Legal Officer Buy 500 $20.00 $10,000 Yes

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

SIMON PROPERTY GROUP (SPG) - Bottom fishing the crash could be intimidating, but it can be easier if you know insiders are on your side. Aeppel Glyn, Director of SPG played safe and bought shares in May at $50, but it is not late at all, the stock is now $90.